Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

UPS shares drop on weak 2024 guidance, job cuts

(Sharecast News) - UPS shares were falling sharply on Tuesday after the transport and logistics giant missed forecasts with its fourth-quarter results and underwhelmed with guidance for 2024, as well as announcing the removal of 12,000 jobs. The world's largest package delivery firm, which employs over 500,000 people worldwide, revealed the job cuts after a disappointing end to 2023, in which revenues fell 7.8% to $24.9bn, undershooting market forecasts of $25.4bn.

Operating profits sunk 22.5% year-on-year to $2.5bn, adjusted diluted earnings per share, which exclude non-recurring items, fell 31.8% year-on-year to $2.47, slightly above the consensus estimate of $2.46.

Revenues in the larger US division, which accounts for over half of group revenues, were down 7.3% at $16.9bn with average daily volumes. falling by 7.4%. International sales were 6.9% lower at $4.6bn as softness in Europe led to an 8.3% fall in average daily volumes.

Meanwhile, supply chain solutions revenue reduced by 11.4% to $3.4bn due mainly to market rate declines and excess market capacity in forwarding, the company explained.

For the full 2023 year, group sales fell 9.3% to $91bn, while adjusted operating profits sunk 28.7% to $9.9bn and the operating margin came in at 10.9%.

Looking ahead, UPS guided to 2024 revenues of $92bn to $94.5bn, under the $95.57bn that the market is currently pricing in, while the operating margin is expected to fall to between 10.0% and 10.6%.

The stock was down nearly 8% shortly after the opening bell on Wall Street at $145.64.

Share this article

Related Sharecast Articles

Oxford Biomedica confident as it moves away from vaccine era
(Sharecast News) - Cell and gene therapy contract development and manufacturing organisation (CDMO) Oxford Biomedica reported stability in its core business on Monday, with a small increase in full-year core revenue for 2023, despite a 36% decrease in total revenue to £89.5m.
N Brown chairman Ron McMillan to retire
(Sharecast News) - N Brown said on Monday that chairman Ron McMillan will be retiring and stepping down from the board with effect from 30 April for personal reasons.
McCarthy out, Adshead in as Ultimate Products chair
(Sharecast News) - Ultimate Products, the parent of homeware brands including Salter and Beldray, announced a change in its leadership on Monday, with James 'Jim' McCarthy deciding to step down as non-executive chair from 31 July.
Digital 9 to make additional revolving credit facility repayment
(Sharecast News) - Infrastructure company Digital 9 Infrastructure announced a significant step towards strengthening its financial position on Monday, with the receipt of a deferred consideration payment of $25m (£20m) related to the sale of the Verne Global group, as announced on 15 March.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.